U.S. Restores Research Funding for South Africa After 18-Month Freeze
The United States National Institutes of Health (NIH) has lifted its suspension on research funding for South African projects, reopening support for scientific programmes that were disrupted for nearly 18 months.
The funding freeze, introduced in early 2025, affected research programmes including studies focused on HIV and tuberculosis. The suspension reportedly resulted in halted clinical trials, job losses and interruptions to major research projects involving South African scientists and institutions.
The decision to restore funding follows an internal directive from NIH leadership which distinguished research grants from traditional foreign aid programmes. South African researchers have welcomed the development, although concerns remain over the damage caused by the prolonged interruption and the need to rebuild affected research capacity.
The renewed funding could help revive stalled medical research and strengthen collaboration between scientists in both countries. However, researchers have urged caution, noting that restoring financial support may not immediately reverse the losses suffered during the funding freeze, particularly the disruption of long-running studies and the loss of skilled research personnel.
